🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL)

RecruitingNAAges 18 Years - 50 YearsAllThe Methodist Hospital Research Institute
NCT06664827 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to identify any differences in elbow ulnar collateral ligament (UCL) relative thickness and joint space laxity in the dominant arm following an 8-week course of low intensity resistance exercises with blood flow restriction (BFR) exercises in healthy volunteers. The main questions it aims to answer are: 1. Do BFR exercises contribute to a change in the relative ligament thickness of the UCL, and changes in the ulnohumeral joint space? 2. Are there changes in arm strength following the 8-week strengthening protocol with/without BFR? Participants will: * Complete two BFR sessions a week for a total of eight weeks. * Complete an exercise session with both arms (dominant arm will receive BFR) at each study visit. * Have sonographs taken of the UCL at the first and last study visit. * Complete strength assessments at the first and last study visit.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Healthy volunteer * Agree to complete all exercise sessions and program in its entirety * Between the ages of 18-50 years old Exclusion Criteria: * Current or recent injury of the hand, elbow, or shoulder * Outside of the ages of 18-50 years old * Vascular compromise or previous vascular surgery * History of DVT * Current participation in other BFR research study * Currently participating in a structured strength training program * Any musculoskeletal conditions resulting in inability to exercise * Participants may not be collegiate/professional baseball/softball players * Vulnerable populations
💊

What it tests

  • Delfi PTS Blood Flow Restriction Tourniquet System
📍

Where

1 site
Houston Methodist Hospital
Houston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy